Abstract
This review highlights the ultrasound findings reported from a number of studies and case reports and discusses the unifying findings from coronavirus disease (COVID-19) patients and from the avian (H7N9) and H1N1 influenza epidemics. We discuss the potential role for portable point-of-care ultrasound (PPOCUS) as a safe and effective bedside option in the initial evaluation, management, and monitoring of disease progression in patients with confirmed or suspected COVID-19 infection.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
Coronavirus Infections / diagnostic imaging*
-
Coronavirus Infections / therapy
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology
-
Female
-
Humans
-
Infection Control
-
Infectious Disease Transmission, Patient-to-Professional / prevention & control
-
Influenza A Virus, H1N1 Subtype / pathogenicity
-
Influenza A Virus, H7N9 Subtype / pathogenicity
-
Influenza, Human / diagnostic imaging
-
Influenza, Human / virology
-
Lung / diagnostic imaging*
-
Lung / virology
-
Male
-
Middle Aged
-
Occupational Exposure / adverse effects
-
Occupational Exposure / prevention & control
-
Pandemics
-
Pneumonia, Viral / diagnostic imaging*
-
Pneumonia, Viral / therapy
-
Pneumonia, Viral / transmission
-
Pneumonia, Viral / virology
-
Point-of-Care Systems*
-
Point-of-Care Testing*
-
Predictive Value of Tests
-
Prognosis
-
Risk Factors
-
SARS-CoV-2
-
Ultrasonography* / adverse effects